When you visit a healthcare provider because of a medical problem, you will be looking for answers concerning your symptoms.
For your healthcare provider to offer you help, the expert will review the details provided to them, and if there is a need, they may gather additional information through testing.
Using those details, healthcare providers may recommend the best treatment option. Some treatment options may include medication.
But recently, drugs have become a one-size-fits-all approach. The pharmacogenomics field has changed how medications are taken and prescribed. Now more than ever, providers use pharmacogenomics for medical health treatments through treatment.
What Pharmacogenomics Is
It refers to the study of the way genes impact people’s response to medications or drugs. Pharmacogenomics, as a field, combines pharmacology to develop safe and effective medications. So it can be described depending on an individual’s genetic makeup.
Most drugs, which are available currently, are one-size-fits-all. However, they don’t work in a similar way for every individual. So it can be hard to predict who can benefit from the medications.
How It Works
Medications interact with the body in various ways, based on where drugs react in the body and how to take them. After taking drugs, your body will need to break them down and get to the intended place.
Your DNA (deoxyribonucleic acid) may affect different steps to influence how you respond to drugs. Great examples of those interactions are;
- Targeted drug development
- Drug breakdown
- Drug uptake
- Drug receptors
Most medications available in the market are targeted toward many people, regardless of the fact that every patient can respond to drugs differently.
Some people can’t experience sufficient response to standard dose because of the extensive metabolism of drugs. But other people are likely to experience serious drug reactions as clearance of drugs is lower than usual.
Uses of Pharmacogenomics
Regardless of the amazing potential in treatments depending on genetic information, this field is still in its infancy stage. Many medical practices and hospitals don’t yet use pharmacogenomics to offer treatment, giving room for growth.
The general focus of the field is limited to chronic conditions with specific approaches to medications. Not every medication has been researched and studied.
And those going research currently, genomic studies are more focused on the condition affecting a large group of individuals, especially those with high-risk situations, such as the use of opiates to treat pain.
The Importance of Pharmacogenomics
With more than eight billion globally, it should come as no surprise that humanity is complex, especially with genetic information.
But unfortunately, the diversity may result in disparities in medical care, which might be hard to account for. Researchers in pharmacogenomics have made an effort to better understand this disparity. Although most lifestyle and cultural causes have been identified already, genetic variations offer a more effective explanation.
Pharmacogenomics has a great future ahead and made vital strides just recently. But it is still in the early phases. More clinical research is required to identify the links between treatment outcomes and genes and, at the same time, clarify the true meaning of this association.